Literature DB >> 7428291

Elevation of plasma neurotensin in the dumping syndrome.

A M Blackburn, N D Christofides, M A Ghatei, D L Sarson, F H Ebeid, D N Ralphs, S R Bloom.   

Abstract

1. The pathophysiology of the dumping syndrome is poorly understood. Plasma levels of four small intestinal hormones have been measured after an oral glucose provocation test in 19 patients with dumping symptoms and in matched controls. 2. Plasma levels of neurotensin, a newly discovered highly potent, hypotensive ileal peptide, were significantly increased in symptomatic patients compared with those of controls [20 min rise of 43 +/- 6.0 (mean +/- SEM) pmol/l in 19 symptomatic patients, 8.0 +/- 5.5 pmol/l in 20 postoperative symptom-free patients, and 4.1 +/- 3.5 pmol/l in 20 pre-operative patients with duodenal ulcer, P < 0.01]. 3. The rise in enteroglucagon was greater than normal but of similar magnitude to that seen in several other gastrointestinal conditions not associated with dumping symptoms. 4. The release of both gastric inhibitory peptide and motilin did not differ significantly from that of controls.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7428291     DOI: 10.1042/cs0590237

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  9 in total

1.  A possible role of GLP-1 in the pathophysiology of early dumping syndrome.

Authors:  Hiroshi Yamamoto; Tsuyoshi Mori; Hiroshi Tsuchihashi; Hiroya Akabori; Hiroyuki Naito; Tohru Tani
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

2.  Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995.

Authors:  W P Hopman; R G Wolberink; C B Lamers; J H Van Tongeren
Journal:  Ann Surg       Date:  1988-02       Impact factor: 12.969

3.  Effects of jejunoileal autotransplantation on gastrointestinal regulatory peptides.

Authors:  T E Adrian; E M Quigley; S G Rose; T J Johnson; J S Thompson
Journal:  Dig Dis Sci       Date:  1994-11       Impact factor: 3.199

4.  Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome.

Authors:  R J Geer; W O Richards; T M O'Dorisio; E O Woltering; S Williams; D Rice; N N Abumrad
Journal:  Ann Surg       Date:  1990-12       Impact factor: 12.969

5.  Plasma peptide YY (PYY) in dumping syndrome.

Authors:  T E Adrian; R G Long; H S Fuessl; S R Bloom
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

6.  Somatostatin and the dumping syndrome.

Authors:  R G Long; T E Adrian; S R Bloom
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-23

Review 7.  Octreotide, a long-acting somatostatin analog, in the management of postoperative dumping syndrome. An update.

Authors:  C B Lamers; A M Bijlstra; A G Harris
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199

8.  [Neurotensin--what is known about its role as a hormone in the gastrointestinal tract?].

Authors:  V E Eysselein
Journal:  Klin Wochenschr       Date:  1984-06-01

Review 9.  International consensus on the diagnosis and management of dumping syndrome.

Authors:  Emidio Scarpellini; Joris Arts; George Karamanolis; Anna Laurenius; Walter Siquini; Hidekazu Suzuki; Andrew Ukleja; Andre Van Beek; Tim Vanuytsel; Serhat Bor; Eugene Ceppa; Carlo Di Lorenzo; Marloes Emous; Heinz Hammer; Per Hellström; Martine Laville; Lars Lundell; Ad Masclee; Patrick Ritz; Jan Tack
Journal:  Nat Rev Endocrinol       Date:  2020-05-26       Impact factor: 43.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.